Heart failure protection through gene therapy

by Medindia Content Team on  January 31, 2003 at 12:57 PM General Health News
RSS Email Print This Page Comment bookmark
Font : A-A+

Heart failure protection through gene therapy
The causes of heart failure are many including genetic abnormalities. Earlier studies have shown that malfunctioning of a gene called phospholamban contributes to heart failure and this discovery is now being used as a basis for a gene therapy approach in protecting against heart failure.

The research which was carried out on hamsters born predisposed to heart failure showed that delivering a gene that helps the heart to contract protects from heart failure. Researchers said that the animals' heart function improved when they were delivered a modified form of the gene phospholamban. They found that those animals who got the gene were protected against heart failure while those who did not get the gene were not protected.

Researchers hope they will be able to use a cardiac catheter to deliver the gene to humans, if further research on pigs, which is underway, proves to be successful.


Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

DNA Finger Printing Congenital Heart Disease Reiki and Pranic Healing Heart Pancreas Healthy Heart Pulmonary Arterial Hypertension Statins Mitral Valve Prolapse Aortic Valve Stenosis 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...